Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer
Journal of Proteome Research · 07.08.2026 · 25 (8) · 3909-3925
DOI: 10.1021/acs.jproteome.5c01124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 15.07.2026. Verfasst von Akbar Ali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian16150, Kelantan, Malaysia. Hauptthemen laut MEDLINE: Metabolomics, Breast Neoplasms, Early Detection of Cancer, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: School of Medical Sciences, Universiti Sains Malaysia.
Abstract (Originalsprache)
Breast cancer (BC) is the most common malignancy among women, and late-stage presentation remains common in Asia, highlighting the need for affordable and minimally invasive adjuncts to imaging. This study evaluated whether fasting serum 1H NMR metabolomics could distinguish Malaysian women with newly diagnosed treatment-naïve BC from healthy controls and identify perturbed metabolic pathways. After spectral quality control exclusion, 101 participants were analyzed (BC, n = 44; control, n = 57). PCA and oOPLS-DA showed group separation, and 14 metabolites were deferred significantly after false discovery rate correction. Endogenous metabolites evaluated in BC included 3-hydroxybutyrate, citrate, glutamine, malonate, phenylalanine, dimethyl sulfone, myo-inositol, and L-carnitine, and the levels of formate, tyrosine, histamine, and p-hydroxyphenylacetate were reduced. Acetylsalicylate and salicylate were classified as exogenous aspirin-related markers and were excluded from the endogenous biomarker panel. Pathway analysis indicated disruptions in the tricarboxylic acid (TCA) cycle, glyoxylate/dicarboxylate metabolism, butanoate metabolism, and amino acid pathways. Metabolite-based classifiers achieved 0.901 accuracy on an internal held-out test partition (AUC 0.942) and 0.902 ± 0.061 accuracy in repeated stratified 5-fold cross-validation. These internally validated findings define a BC-associated serum metabolomic signature in a Southeast Asian cohort and warrant independent external validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian16150, Kelantan, Malaysia.
- Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, Kuala Nerus21030, Terengganu, Malaysia.
- Department of Pathology, School of Medical Science, Health Campus, Universiti Sains Malaysia, Kubang Kerian16150, Kelantan, Malaysia.
- Department of Surgery, School of Medical Science, Health Campus, Universiti Sains Malaysia, Kubang Kerian16150, Kelantan, Malaysia, Maya Mazuwin Yahya.
- Anesthesia and Intensive Care Unit, National Heart Institute, Kuala Lumpur50400, Malaysia.
- Faculty of Medicine Universiti Sultan Zainal Abidin , Kuala Terengganu20400, Terengganu, Malaysia.
ORCID-Profile: Akbar Ali, Tengku Ahmad Damitri Al Astani Tengku Din
Förderung
- School of Medical Sciences, Universiti Sains Malaysia
Zitieren
APA
Ali, A., Tengku Din, T. A. D. A. A., Maulidiani, M., Arafat, H. M., Abdul Rahman, W. F. W., Mazuwin Yahya, M., Kadiman, S., Ramli, R. A. B., & Wan Azman, W. N. (2026). Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer. Journal of Proteome Research, 25(8), 3909-3925. https://doi.org/10.1021/acs.jproteome.5c01124
Vancouver
Ali A, Tengku Din TADAA, Maulidiani M, Arafat HM, Abdul Rahman WFW, Mazuwin Yahya M, et al. Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer. Journal of Proteome Research. 2026;25(8):3909-3925. doi:10.1021/acs.jproteome.5c01124
BibTeX
@article{Ali2026,
author = {Ali, Akbar and Tengku Din, Tengku Ahmad Damitri Al Astani and Maulidiani, Maulidiani and Arafat, Heba Mohammed and Abdul Rahman, Wan Faiziah Wan and Mazuwin Yahya, Maya and Kadiman, Suhaini and Ramli, Ras Azira Binti and Wan Azman, Wan Norlina},
title = {Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {8},
pages = {3909--3925},
doi = {10.1021/acs.jproteome.5c01124}
}
EUVIMED